SCHEMBL23254239

SCHEMBL23254239

O=C(Cl)CCC1CCc2c(sc3ncnc(Cl)c23)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
CSNK2A2 P19784 3/20 0.47
CSNK2B P67870 3/20 0.47
CSNK2A1 P68400 3/20 0.47
LMNA P02545 1/20 0.47
LIMK1 P53667 5/20 0.46
HTT P42858 3/20 0.43
KDM4E B2RXH2 2/20 0.43
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
MAPT P10636 2/20 0.42
TP53 P04637 1/20 0.41
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
POLB P06746 2/20 0.38
CYP1A2 P05177 1/20 0.38
HPGD P15428 1/20 0.38
CYP2C19 P33261 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5630969 0.84 CSNK2A2 (0.51) ALDH1A1CSNK2A2CSNK2BCSNK2A1LMNA
SCHEMBL10343608 0.81 HTT (0.63) ALDH1A1CSNK2A2CSNK2BCSNK2A1LMNA
SCHEMBL19523758 0.81 HTT (0.63) ALDH1A1CSNK2A2CSNK2BCSNK2A1LMNA
SCHEMBL16384794 0.80 LIMK1 (0.59) ALDH1A1CSNK2A2CSNK2BCSNK2A1LMNA
SCHEMBL16741476 0.80 LIMK1 (0.59) ALDH1A1CSNK2A2CSNK2BCSNK2A1LMNA
SCHEMBL16371779 0.80 LIMK1 (0.59) ALDH1A1CSNK2A2CSNK2BCSNK2A1LMNA
SCHEMBL18863898 0.79 HTT (0.43) ALDH1A1CSNK2A2CSNK2BCSNK2A1LMNA
SCHEMBL14459798 0.78 LIMK1 (0.54) ALDH1A1CSNK2A2CSNK2BCSNK2A1LMNA
SCHEMBL16741326 0.77 LIMK1 (0.59) ALDH1A1CSNK2A2CSNK2BCSNK2A1LMNA
SCHEMBL16370982 0.77 LIMK1 (0.59) ALDH1A1CSNK2A2CSNK2BCSNK2A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233866-B1 PYRAZOLOPYRIDINAMINES AS MKNK1 AND MKNK2 INHIBITORS Bayer Pharma AG (DE) 2021-04-21 EP disclosed